Quinn Opportunity Partners’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$486K Hold
46,240
0.03% 272
2025
Q4
$532K Sell
46,240
-63,760
-58% -$985K 0.02% 276
2025
Q3
$2.67M Buy
110,000
+99,000
+900% +$1.65M 0.19% 113
2025
Q2
$181K Hold
11,000
0.02% 304
2025
Q1
$200K Hold
11,000
0.01% 334
2024
Q4
$408K Hold
11,000
0.03% 280
2024
Q3
$352K Hold
11,000
0.03% 218
2024
Q2
$903K Buy
11,000
+800
+8% +$86.5K 0.1% 137
2024
Q1
$1.48M Buy
+10,200
New +$861K 0.16% 113
2020
Q4
Sell
-1,500
Closed -$297K 234
2020
Q3
$297K Buy
+1,500
New +$1.09M 0.03% 160

Other funds holding CDLX

Quinn Opportunity Partners's CDLX Position: Q1 2026 in Review

Quinn Opportunity Partners held its Cardlytics (CDLX) position steady in Q1 2026 at 46,240 shares worth $486K. The position accounts for 0.03% of the portfolio, ranked #272.

Quinn Opportunity Partners first reported a position in CDLX in Q3 2020 and has held it in 10 quarters since. The position peaked at $2.67M in Q3 2025. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Quinn Opportunity Partners held 46,240 shares of Cardlytics worth $486K as of Q1 2026.
  • Quinn Opportunity Partners left its Cardlytics share count unchanged in Q1 2026.
  • Cardlytics made up 0.03% of Quinn Opportunity Partners's portfolio in Q1 2026, its #272 holding.
  • Quinn Opportunity Partners first reported a position in Cardlytics in Q3 2020 and has held it in 10 quarters since.
  • Quinn Opportunity Partners's Cardlytics position peaked at $2.67M in Q3 2025.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.